New Needle-Freeze? muscle shot chickenpox vaccine tested in toddlers

NCT ID NCT06855160

Recruiting now ⭐️ VACCINE ⭐️ Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new chickenpox vaccine given as a muscle injection in healthy children aged 12 to 15 months. It compares the immune response and safety of this vaccine to the standard shot given under the skin. The study also looks at combining it with the MMR vaccine. About 911 children will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chickenpox prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHICKENPOX

Contacts and locations

Locations

GSK Investigational Site
RECRUITING

Tucson, Arizona, 85704, United States
GSK Investigational Site
RECRUITING

Huntington Park, California, 90255, United States
GSK Investigational Site
RECRUITING

Sherman Oaks, California, 91403, United States
GSK Investigational Site
RECRUITING

Coral Gables, Florida, 33134, United States
GSK Investigational Site
RECRUITING

Miami Lakes, Florida, 33014, United States
GSK Investigational Site
RECRUITING

Tampa, Florida, 33612, United States
GSK Investigational Site
RECRUITING

Idaho Falls, Idaho, 83404, United States
GSK Investigational Site
RECRUITING

Dayton, Ohio, 45414, United States
GSK Investigational Site
RECRUITING

Houston, Texas, 77584, United States
GSK Investigational Site
RECRUITING

Lewisville, Texas, 75067, United States
GSK Investigational Site
RECRUITING

Mansfield, Texas, 76063, United States
GSK Investigational Site
RECRUITING

Pharr, Texas, 78577, United States
GSK Investigational Site
RECRUITING

Richmond, Virginia, 23294, United States
GSK Investigational Site
RECRUITING

Alken, 3570, Belgium
GSK Investigational Site
RECRUITING

Tartu, 50106, Estonia
GSK Investigational Site
WITHDRAWN

Athens, 115 27, Greece
GSK Investigational Site
RECRUITING

Athens, 11527, Greece
GSK Investigational Site
RECRUITING

Thessaloniki, 54642, Greece
GSK Investigational Site
RECRUITING

Trzebnica, 55-100, Poland
GSK Investigational Site
RECRUITING

Brasov, 500283, Romania
GSK Investigational Site
RECRUITING

Calarasi, 910160, Romania
GSK Investigational Site
RECRUITING

Chiang Mai, 50200, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.